TCL Archive NCI To Fund About 4,100 Grants; Increase Planned In Average Costs; Paylines Stable November 20, 1998
TCL Archive MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer. March 2, 2001